Something Happened in Biotech Last Week…Update-1
Update-1 5/9/23 Biotech holding up nicely. XBI up 1.48% to $86 handle. CRSP up 14% to $64 handle, NTLA up 2%. GILD in buying range under $80 with 3.76% dividend, FWD PE of 10.9 and strong position in HIV/Aids, viral hepatitis, coronaviruses and emerging portfolio in oncology. ABOS up 18% to...
SMID Life Science Stock Portfolio: Some Good Picks in a Stalled Sector…Update-2 biotech rally continues
Update-2 5/5....11a EDT Biotech rally continues with strength in SMID stocks: up 1.9% to $85 handle. Gene therapy stocks strong: CRSP EDIT NTLA. IWM up 1.83%to 1750. Spec small caps up big: Acumen (ABOS) up 30% on AD research , VCYT ARKG flat at $29 level. Mid cap winners: AGIO ARWR LGND RCKT...
Healthcare Sector Update: MedTech Trending Up. Update-1 Brief Recap
Healthcare Stocks-Brief Recap for the Week ending 4/28 A nice steady day holding on to gains with the Russell 2000 up 1.015, the NASDAQ up 0.69%,DOW 30 up 0.8% and the S&P 500 up 0.83%. Life science ETFs for the WEEK: XLV down 0.57% to $133..53, IBB down 2.21% to $130.51, XBI down 2.52%...
April Is Busting Out For Healthcare and Biotech… Update-3…MedTech
4/19/23 1:30 P EDT...Update-3..Added to MedTech weighting in healthcare portfolios: ABT,HOLX, IHI. Talc liabilities weighing on JNJ shares, but sales growth up 5.6%, MedTech bright spot up 7.3%. Abbott (ABT) soars over 7% to $112 level on earnings with recovery in device sales increases...
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags…Updates-2…JNJ, UNH, XLV
Update-2 4/5/23...2:20p EDT..Healthcare and other defensive groups continue to run up as concerns grow about rising rates in a slowing economy. Biopharma +2% movers:AZN, GSK, LLY, MRK,PFE, RHHBY, VRTX. UNH up 3.48% to $510,XLV up 1.79% to $133.28. SMID lagging with XBI down 0.59% to 75+; CRSP...